Moderna turns to biotech startup to ramp up Covid vaccine manufacturing

Moderna will turn to a biotech startup, National Resilience, to manufacture additional doses of its Covid-19 vaccine.

Moderna had previously said it would manufacture 800 million to 1 billion doses of its Covid-19 vaccine in 2021, ramping up to 3 billion doses in 2022.  A person familiar with the company said the collaboration might result in hundreds of millions more doses. Currently, the vaccine is given as a two-dose series, though Moderna has said at least some patients may need a third dose given many months later.

Read the rest…

Moderna turns to biotech startup to ramp up Covid vaccine manufacturing

Leave a Reply

Your email address will not be published. Required fields are marked *

Scroll to top